Velocity11是生命科學(xué)實(shí)驗(yàn)室自動(dòng)化和機(jī)器人解決方案的領(lǐng)先廠商。 安捷倫科技有限公司（NYSE: A）和Velocity11公司于2007年11月7日共同宣布他們已經(jīng)簽訂了安捷倫收購(gòu)Velocity11的最終協(xié)議。Velocity11是一家私人公司，在生命科學(xué)市場(chǎng)上其是自動(dòng)化液體處理和試驗(yàn)室機(jī)器人的領(lǐng)導(dǎo)廠商。具體細(xì)節(jié)未被透露，此收購(gòu)預(yù)期在30天到60天內(nèi)完成。 此收購(gòu)將使安捷倫能夠提供更多的全面的工作流程解決方案，為其在醫(yī)藥、生物科技和科學(xué)研究市場(chǎng)。Velocity11主要是設(shè)計(jì)、制造和銷售機(jī)器人解決方案，從單機(jī)儀表開始到高級(jí)自動(dòng)化解決方案再到大型多扶手機(jī)器人系統(tǒng)。公司還開發(fā)了世界級(jí)的軟件用于控制機(jī)器人。Velocity11的技術(shù)通過廣泛的應(yīng)用將加強(qiáng)安捷倫自動(dòng)化樣品準(zhǔn)備解決方案。 安捷倫生命科學(xué)和解決方案部的副總裁Nick Roelofs說：“Velocity11在技術(shù)創(chuàng)新、產(chǎn)品質(zhì)量和服務(wù)方面有著極好的聲譽(yù)，他是實(shí)驗(yàn)室解決方案的領(lǐng)導(dǎo)者。同時(shí)地，我們可以為客戶提供一套用于自動(dòng)化的全面工作流程，幫助加速解決阻力和遺傳方面的研究。在收購(gòu)?fù)瓿芍畷r(shí)，用戶將斷續(xù)收到來自Velocity11的個(gè)性化服務(wù)，還加上來自安捷倫強(qiáng)大的網(wǎng)絡(luò)服務(wù)和支持?！? Velocity11的首席執(zhí)行官Rob Nail說：“我們很高興能加入像安捷倫擁有如此完整公司文化、產(chǎn)品生產(chǎn)線、極高客戶滿意度和全套自動(dòng)化工作流程解決方案模式的公司。安捷倫的全球架構(gòu)和嘗試應(yīng)有將允許我們繼續(xù)提高我們提供給我們客戶的服務(wù)、創(chuàng)新方面的新方向以迅速擴(kuò)展我們的解決方案?！? 安捷倫將為Velocity11的約150名員工提供的工作。Velocity11成立于1999年，總部位于加利福尼亞Menlo Park，第二個(gè)辦公室位于英國(guó)哈福德郡的Melbourn，為美國(guó)和西歐提供全面的服務(wù)支持。 Velocity11被認(rèn)為是在硅谷企業(yè)和北美區(qū)域中發(fā)展最快企業(yè)中的一個(gè)。2006年，Velocity11被Deloitte列入美國(guó)快速發(fā)展企業(yè)名單之中。 [FONT=times] original text [/FONT] [font=times][Color=#708090]Agilent Technologies Inc. （NYSE: A） and Velocity11 today announced that they have signed a definitive agreement for Agilent to acquire Velocity11. Velocity11, privately held, is a leader in automated liquid handling and laboratory robotics for the life science market. Financial details were not disclosed. The acquisition is expected to be final in 30 to 60 days, subject to certain closing conditions. The acquisition will enable Agilent to offer a more comprehensive suite of workflow solutions to its life science customers in the pharmaceutical, biotech and academic research markets. Velocity11 designs, manufactures and markets robotic solutions that range from standalone instrumentation to bench-top automation solutions to large, multi-armed robotic systems. The company also develops world-class software to control the robotics. Velocity11‘s technology will strengthen Agilent‘s offering of automated sample-preparation solutions across a broad range of applications. "Velocity11 is a market leader in lab automation with a solid reputation for innovative technology, quality products and superb customer service," said Nick Roelofs, vice president of Agilent‘s Life Science Systems and Solutions Unit. "Together, we can offer customers a comprehensive set of workflow solutions with increased levels of automation, which can help speed drug discovery and genetic research. When the acquisition is final, customers will continue to experience the same personalized customer service they‘ve come to expect from Velocity11, with the addition of Agilent‘s strong network of global service and support." "We are very excited to be joining Agilent and to have found a company with such a complementary culture, product line, commitment to customer satisfaction and vision for providing complete automated workflow solutions," said Rob Nail, Velocity11‘s CEO. "The ability to leverage Agilent‘s global infrastructure and deep applications focus will allow us to continue to improve the services we provide our customers, innovate in new directions, and rapidly expand our reach worldwide." Agilent is offering jobs to substantially all of Velocity11‘s approximately 150 employees worldwide. Headquartered in Menlo Park, Calif., Velocity11 has a second office in Melbourn, Hertfordshire, U.K., with field sales and support offered throughout the U.S. and western Europe. The company was established in 1999. Velocity11 has been recognized as one of the fastest growing companies in Silicon Valley （"Silicon Valley Fast 50" list） and in North America （"Technology Fast 500" list and Inc. 500 list）. In 2006, Velocity11 was named to Deloitte‘s "Fastest Growing U.S. Tech Company" list.[/color][/font]